Based in St. Paul, Minnesota, Aria CV was founded in 2010 by Drs. John Scandurra and Karl Vollmers, following development work the two had done at the University of Minnesota's Earl E. Bakken Medical Devices Center. Aria has performed a successful acute first in human clinical study in Vienna, Austria and is now preparing for a U.S. clinical trial under the FDA's Early Feasibility Study Program to evaluate long term implants in PAH patients.

Key Contact

Funding Events

Date	Amount	Type	Investors	Valuation
02/25/20	$31,000,000	Series B	BioStar Ventures Catalyst Health Ventures Cedar Point Capital Frontcourt Ventures Longview Ventures Xeraya Capital	undisclosed